Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer

This comparative effectiveness study assesses the numbers needed to treat in targeted trials of agents for newly diagnosed ovarian cancer.

Detalles Bibliográficos
Autores principales: Bartoletti, Michele, Pignata, Sandro, Lorusso, Domenica, Perrone, Francesco, Zara, Diego, Puglisi, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719047/
https://www.ncbi.nlm.nih.gov/pubmed/36459141
http://dx.doi.org/10.1001/jamanetworkopen.2022.45077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719047/
https://www.ncbi.nlm.nih.gov/pubmed/36459141
http://dx.doi.org/10.1001/jamanetworkopen.2022.45077

Ejemplares similares